
How can pharma embrace and interact with increasingly informed and demanding patients to bring positive outcomes for all?

How can pharma embrace and interact with increasingly informed and demanding patients to bring positive outcomes for all?

Keeping skittish patients on their medicines ought to be a strategic priority for Big Pharma - but is it? Pharm Exec convenes an expert round table to examine how best to make progress and agree on some practical steps for incorporation in the campaign agenda.

The rise of advocacy groups has helped patients find their voice, but the power to change health profiles remains an elusive goal.

A Q&A with Andrew Webber, President and CEO of the National Business Coalition on Health

Pharmaceutical Executive
To decide on a course of treatment, patients need to be told the truth straight up

The simpler the explanation of a disorder and its treatment, the better able a patient is to take proper care of himself

Pharmaceutical Executive
When neither attitudes nor personality drive behavior, Pharma must look to social norms to understand consumer adherence issues